Skip to main content
NCBI home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2004 Jan;19(1):138–141. doi: 10.1007/BF02872409

Role of oxidative stress and antioxidants in aetiopathogenesis and management of oral submucous fibrosis

Soma Gupta 1,✉, M V R Reddy 1, B C Harinath 1,✉
PMCID: PMC3453921  PMID: 23105446

Abstract

Lipid peroxidation product, malonaldehyde (MDA) and antioxidants were estimated in plasma and erythrocytes of 34 cases of oral submucous fibrosis (OSMF) of different grades with equal number of healthy controls to evaluate the association of reactive oxygen species (ROS) and OSMF. While plasma MDA was found to be significantly higher in patients (3.3±0.4 nmole/ml, P<0.001) as compared to controls (2.4±0.5 nmole/ml), plasma beta carotene and vitamin E levels were found to be decreased significantly in patients (81.7±14.3 μg/100 ml, P<0.001; 9.3±0.9 mg/L, P<0.01 respectively) with respect to healthy controls (110±20.8 μg/100 ml and 10.1±1.2 mg/L). The decrease in beta-carotene and vitamin E was found to be more significant in OSMF grade II and III than in grade I. After 6 weeks of oral administration of beta-carotene and vitamin E, patients showed increase in plasma level of these two antioxidants along with decrease in MDA level associated with clinical improvement.

Key words: Beta-carotene, MDA, OSMF, ROS, Vitamin E

Full Text

The Full Text of this article is available as a PDF (299.8 KB).

References

  • 1.Gupta P.C., Sinor P.N., Bhonsle R.B., Pawar V.S., Mehta H.C. Oral submucous fibrosis in India, A new epidemic? Natl. Med. J. India. 1998;11:113–116. [PubMed] [Google Scholar]
  • 2.Pindborg J.J. Oral submucous fibrosis as a precancerous condition. Scand. J. Dent. Res. 1984;92:224–229. doi: 10.1111/j.1600-0722.1984.tb00883.x. [DOI] [PubMed] [Google Scholar]
  • 3.Gupta P.C., Bhosle R.B., Murti P.R., Daftary D.K., Mehta F.S., Pindborg J.J. An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special references to nodular lenkoplakia. Cancer. 1989;63:2247–2252. doi: 10.1002/1097-0142(19890601)63:11&#x0003c;2247::AID-CNCR2820631132&#x0003e;3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  • 4.Rajendran R. Oral submucous fibrosis: Etiology, pathogenesis and future research. Bull. WHO. 1994;72:985–986. [PMC free article] [PubMed] [Google Scholar]
  • 5.Pindborg J.J. Oral submucous fibrosis: A review. Ann. Acad. Med. 1989;18:603–607. [PubMed] [Google Scholar]
  • 6.Chaturvedi V.N., Marathe M.G. Oral submucous fibrosis. Natl. Med. J. India. 1989;17:11–17. [Google Scholar]
  • 7.Sun Yi. Free radicals, antioxidant enzymes and carcinogenesis. Free Radical Biol. Med. 1990;8:583–599. doi: 10.1016/0891-5849(90)90156-D. [DOI] [PubMed] [Google Scholar]
  • 8.Freeman B.A., Crapo J.D. Free radicals and Tissue injury. Lab. Invest. 1982;47:412–425. [PubMed] [Google Scholar]
  • 9.Sen C.K. Oxygen toxicity and antioxidants: State of the art. Ind. J. Physiol. Pharmacol. 1995;39:177–196. [PubMed] [Google Scholar]
  • 10.Garewal H.S. Response of oral leukoplakia to beta carotene. J. Clin. Oncol. 1990;8:1717–1720. doi: 10.1200/JCO.1990.8.10.1715. [DOI] [PubMed] [Google Scholar]
  • 11.Bhatt A.P., Dholakia H.M. Mast cell density in oral submucous fibrosis. J. Ind. Dent. Assoc. 1977;49:187–191. [Google Scholar]
  • 12.Kumar K., Shrivastava C.M., Mathur R.M., Pradhan R. The effect of collagenase on oral submucous fibrosis. J. Ind. Dent. Assoc. 1980;52:243–246. [Google Scholar]
  • 13.Satoh K. Serum lipid peroxide in cerebro vascular disorders determined by a new colorimetric method. Clin. Chem. Acta. 1978;90:37–43. doi: 10.1016/0009-8981(78)90081-5. [DOI] [PubMed] [Google Scholar]
  • 14.Bieri J.G., Teets L., Belavady B., Andrews E.L. Serum vitamin E levels in a normal adult population in the Washington D.C. area. Arch. Proc. Soc. Exp. Biol. Med. 1964;117:131–133. doi: 10.3181/00379727-117-29515. [DOI] [PubMed] [Google Scholar]
  • 15.Marklund S., Marklund G. Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1974;47:469–474. doi: 10.1111/j.1432-1033.1974.tb03714.x. [DOI] [PubMed] [Google Scholar]
  • 16.Halliwell B., Chirico S. Lipid peroxidation: Its mechanism measurement and significance. Am. J. Clin. Nutr. 1993;57(Suppl):715S–725S. doi: 10.1093/ajcn/57.5.715S. [DOI] [PubMed] [Google Scholar]
  • 17.Frei B. Reactive oxygen species and antioxidant vitamins: Mechanism of action. Am. J. Med. 1994;97:5 S–13 S. doi: 10.1016/0002-9343(94)90292-5. [DOI] [PubMed] [Google Scholar]
  • 18.Borle R.M., Borle S.R. Management of oral submucous fibrosis. Am. Assoc. Oral Maxillofacial Surgeons. 1991;49:788–791. doi: 10.1016/0278-2391(91)90002-4. [DOI] [PubMed] [Google Scholar]
  • 19.Maher R., Aga P., Johnson N.W., Sankaranarayanan R., Warnakulasuriya S. Evaluation of multiple micronutrient supplementation in the management of oral submucous fibrosis in Karachi, Pakistan. Nutr. Cancer. 1997;27:41–47. doi: 10.1080/01635589709514499. [DOI] [PubMed] [Google Scholar]
  • 20.Roth G.N., Chandra A., Nair M.G. Novel bioactivities ofCurcuma longa constituents. J. Nat. Prod. 1998;61:542–545. doi: 10.1021/np970459f. [DOI] [PubMed] [Google Scholar]
  • 21.Chang Y.C., Hu C.C., Tseng T.H., Tai K.W., Lii C.K., Chou M.Y. Synergistic effects of nicotine on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts. J. Oral Pathol. Med. 2001;30:458–64. doi: 10.1034/j.1600-0714.2001.030008458.x. [DOI] [PubMed] [Google Scholar]
  • 22.Chang Y.C., Huang F.M., Tai K.W., Yang L.C., Chou M.Y. Mechanisms of cytotoxicity of nicotine in human periodontal ligament fibroblast culture. J. Periodontal Res. 2002;37:279–285. doi: 10.1034/j.1600-0765.2002.01612.x. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES